WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

Point of Care Testing (POCT): defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care.[1][2] This contrasts with the historical pattern in ...

ED professionals are required to deal with uncertainty on a daily basis. Various tests must be provided to patients with diffuse symptoms, extending waiting times for lab results, overcrowding wards ...

Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy To put it another way ...

COVID-19 has driven an uptick in healthcare delivery approaches like telemedicine and point-of-care, home, and direct-to-consumer testing, a shift that some observers believe could continue to ...

LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

Point of Care Testing (POCT): defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care.[1][2] This contrasts with the historical pattern in ...